1. Home
  2. ABOS vs BZFD Comparison

ABOS vs BZFD Comparison

Compare ABOS & BZFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABOS
  • BZFD
  • Stock Information
  • Founded
  • ABOS 1996
  • BZFD 2006
  • Country
  • ABOS United States
  • BZFD United States
  • Employees
  • ABOS N/A
  • BZFD N/A
  • Industry
  • ABOS Biotechnology: Pharmaceutical Preparations
  • BZFD Movies/Entertainment
  • Sector
  • ABOS Health Care
  • BZFD Consumer Discretionary
  • Exchange
  • ABOS Nasdaq
  • BZFD Nasdaq
  • Market Cap
  • ABOS 76.9M
  • BZFD 77.5M
  • IPO Year
  • ABOS 2021
  • BZFD N/A
  • Fundamental
  • Price
  • ABOS $1.08
  • BZFD $2.16
  • Analyst Decision
  • ABOS Strong Buy
  • BZFD
  • Analyst Count
  • ABOS 3
  • BZFD 0
  • Target Price
  • ABOS $7.33
  • BZFD N/A
  • AVG Volume (30 Days)
  • ABOS 206.3K
  • BZFD 449.7K
  • Earning Date
  • ABOS 03-27-2025
  • BZFD 03-13-2025
  • Dividend Yield
  • ABOS N/A
  • BZFD N/A
  • EPS Growth
  • ABOS N/A
  • BZFD N/A
  • EPS
  • ABOS N/A
  • BZFD N/A
  • Revenue
  • ABOS N/A
  • BZFD $189,887,000.00
  • Revenue This Year
  • ABOS N/A
  • BZFD $89.62
  • Revenue Next Year
  • ABOS N/A
  • BZFD $4.50
  • P/E Ratio
  • ABOS N/A
  • BZFD N/A
  • Revenue Growth
  • ABOS N/A
  • BZFD N/A
  • 52 Week Low
  • ABOS $1.05
  • BZFD $1.26
  • 52 Week High
  • ABOS $4.06
  • BZFD $5.68
  • Technical
  • Relative Strength Index (RSI)
  • ABOS 34.99
  • BZFD 47.56
  • Support Level
  • ABOS $1.14
  • BZFD $2.04
  • Resistance Level
  • ABOS $1.28
  • BZFD $2.23
  • Average True Range (ATR)
  • ABOS 0.10
  • BZFD 0.15
  • MACD
  • ABOS -0.01
  • BZFD 0.02
  • Stochastic Oscillator
  • ABOS 6.98
  • BZFD 27.11

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

About BZFD BuzzFeed Inc.

BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.

Share on Social Networks: